On Friday, December 11th, 2015, a Philadelphia jury found for the plaintiff, Tim Stange in a case against Janssen Pharmaceuticals, the makers of Risperdal. In this case, the plaintiff, Mr. Stange was awarded $500,000 after several hours of jury deliberations. Establishing a link between Risperdal and Gynecomastia, which is a swelling of breast tissue and the development of breasts in boys and men caused by hormone imbalances was central to the case.. Tim Stange took Risperdal from 2006 to 2009 to help address symptoms of Tourette syndrome and subsequently developed male breasts and pain related to his condition.
Linking Risperdal to Gynecomastia
The trial represents the third settlement awarded against Risperdal’s maker, Janssen Pharmaceuticals a Johnson & Johnson company. According to court docs, a month into the case, Judge Kenneth Powell for the Philadelphia Court of Common Please ordered Janssen to produce documents, emails and other non-privileged information in relation to “reanalysis data” which attempted downplay the linkage between Risperdal and Gynecomastia and the warning labels of associated risks. It would seem that the jury, felt that Janssen /Johnson & Johnson were trying to hide and obscure findings. A new research study created by journalist Steve Brill, has documented a similar case against J&J in America’s Most Admired Lawbreaker which he recently posted to the HuffingtonPost.com
Implications for 1,500 cases pending and those not yet filed
This third Risperdal case represents a significant settlement victory against Johnson & Johnson. There are more than 1.500 cases heading for trial and other yet to be documented and heard by the courts. Experts, like Steve Brill suggest we may see this move toward a “massive settlement,” but for now cases are proceeding through the courts.
Get the legal help you need
Should you or a loved one you know be suffering as a result of Risperdal treatments, please consider seeking legal help to ensure your legal rights are protected.